DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lunesta (Eszopiclone) - Published Studies

 

-- advertisement --

Lunesta Related Published Studies

Well-designed clinical trials related to Lunesta (Eszopiclone)

Next-day cognition, psychomotor function, and driving-related skills following nighttime administration of eszopiclone. [2008.07]

A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia. [2008.06.15]

Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. [2008.05]

Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. [2007.08.01]

Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. [2007.02.15]

Eszopiclone in patients with insomnia during perimenopause and early postmenopause: a randomized controlled trial. [2006.12]

A polysomnography study of eszopiclone in elderly patients with insomnia. [2006.09]

Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. [2006.06.01]

An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. [2005.11]

A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. [2005.06.01]

An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults. [2005.01]

Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. [2004.12]

Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. [2003.11.01]

Well-designed clinical trials possibly related to Lunesta (Eszopiclone)

The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone. [2006.08]

Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial. [2006.06.28]

Sequential combinations of drug and cognitive behavioral therapy for chronic insomnia: an exploratory study. [2005.12]

Next-day residual effects of hypnotics in DSM-IV primary insomnia: a driving simulator study with simultaneous electroencephalogram monitoring. [2005.10]

Sleep-inducing pharmaceuticals: a comparison of melatonin, zaleplon, zopiclone, and temazepam. [2004.06]

Comparison of lorazepam and zopiclone for insomnia in patients with stroke and brain injury: a randomized, crossover, double-blinded trial. [2004.06]

Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. [2003.12]

Effects on postural oscillation and memory functions of a single dose of zolpidem 5 mg, zopiclone 3.75 mg and lormetazepam 1 mg in elderly healthy subjects. A randomized, cross-over, double-blind study versus placebo. [2003.07]

[Study of the real situation of improvement by Zopiclone in treatment of insomnia among persons working during night shifts] [2002.11]

[Comparison of zopiclone and midazolam premedication for preoperative anxiolysis] [2002.10]

Melatonin and zopiclone: the relationship between sleep propensity and body temperature. [2002.05.01]

Differential residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. [2002.03.15]

Actigraphic assessment of the preoperative hypnotic effects of brotizolam and zopiclone. [2002]

Efficacy and safety of tianeptine in major depression: evidence from a 3-month controlled clinical trial versus paroxetine. [2002]

Melatonin and zopiclone as pharmacologic aids to facilitate crew rest. [2001.11]

[Homeopathic specialties as substitutes for benzodiazepines: double-blind vs. placebo study] [2001.07]

A double-blind, randomized and placebo-controlled study on the polysomnographic withdrawal effects of zopiclone, zolpidem and triazolam in healthy subjects. [2001.06]

A double-blind comparative study of zolpidem versus zopiclone in the treatment of chronic primary insomnia. [2001.05]

The effect of single oral doses of zopiclone on nocturnal melatonin secretion in healthy male volunteers. [2001.05]

The effects of zolpidem and zopiclone on daytime sleepiness and psychomotor performance. [2000.08]

Effects of zolpidem and zopiclone on cognitive and attentional function in young healthy volunteers: an event-related potential study. [2000.02]

Effect of zopiclone and temazepam on sleep EEG parameters, psychomotor and memory functions in healthy elderly volunteers. [2000.01]

Residual effects of hypnotics on disengagement of spatial attention. [2000]

Independent sleep EEG slow-wave and spindle band dynamics associated with 4 weeks of continuous application of short-half-life hypnotics in healthy subjects. [1999.11]

The effects of substituting zopiclone in withdrawal from chronic use of benzodiazepine hypnotics. [1998.12]

Rebound insomnia after hypnotic withdrawal in insomniac outpatients. [1998]

Zopiclone as night medication in rheumatoid arthritis. [1998]

Effect of zopiclone on sleep, night-time ventilation, and daytime vigilance in upper airway resistance syndrome. [1997.11]

Multidrug comparison (lorazepam, triazolam, zolpidem, and zopiclone) in situational insomnia: polysomnographic analysis by means of the cyclic alternating pattern. [1997.06]

Concentrations and effects of zopiclone are greatly reduced by rifampicin. [1997.05]

Is hypnotic withdrawal facilitated by the transitory use of a substitute drug? [1997.01]

A comparison of zopiclone and propiomazine as hypnotics in outpatients: a multicentre, double-blind, randomized, parallel-group comparison of zopiclone and propiomazine in insomniacs. [1997]

Relationship between the effects of a hypnotic drug, zopiclone, on polysomnography and on daytime EEGs. [1997]

Zopiclone pharmacodynamics: by monitoring event-related potentials and psychometric scores. [1996.08]

Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone. [1996]

[Study of zopiclone with quantitative EEG analysis and topography] [1995.08]

Double-blind comparison of zopiclone and flunitrazepam in elderly insomniacs with special focus on residual effects. [1995]

ECG activity in the sleep of insomniac patients under the influence of lormetazepam and zopiclone. [1995]

Zopiclone as a preoperative night hypnotic: a double-blind comparison with temazepam and placebo. [1994.04]

Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo. [1994.01]

Effects of zopiclone, triazolam, and nitrazepam on standing steadiness. [1994]

Suriclone enhances the actions of chlorpromazine on human psychomotor performance but not on memory or plasma prolactin in healthy subjects. [1994]

Effects of zopiclone on slow wave sleep and spontaneous K-complexes for normal healthy young adults. [1993.12]

Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. [1993.06]

[Periodic discharges of sleep spindles with placebo and zopiclone] [1992.12]

A comparison of efficacy and tolerance of the short acting sedatives midazolam and zopiclone. [1992.10.28]

Interactions and comparative effects of zopiclone, diazepam and lorazepam on psychomotor performance and on elimination pharmacokinetics in healthy volunteers. [1992.02]

Pattern recognition by matched filtering: an analysis of sleep spindle and K-complex density under the influence of lormetazepam and zopiclone. [1992]

Zopiclone in the treatment of sleep abnormalities in fibromyalgia. [1991]

Effects of hypnotics on sleep and psychomotor performance. A double-blind randomised study of lormetazepam, midazolam and zopiclone. [1990.12]

Zopiclone versus flurazepam in insomnia: prolonged administration and withdrawal. [1990.10]

Actions of zopiclone and carbamazepine, alone and in combination, on human skilled performance in laboratory and clinical tests. [1990.09]

Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. [1990.07]

A double-blind placebo-controlled trial of zopiclone 7.5 mg and temazepam 20 mg in insomnia. [1990.07]

The effect of zopiclone 7.5 mg on the sleep, mood and performance of shift workers. [1990.04]

A comparison of the efficacy, tolerance and residual effects of zopiclone, flurazepam and placebo in insomniac outpatients. [1990.04]

Zopiclone versus triazolam in insomniac geriatric patients: a specific increase in delta sleep with zopiclone. [1990.04]

Efficacy and safety of zopiclone and triazolam in the treatment of geriatric insomniacs. [1990.04]

A comparison of the efficacy, safety and withdrawal effects of zopiclone and triazolam in the treatment of insomnia. [1990.04]

A comparative study of zopiclone and triazolam in patients with insomnia. [1990.04]

Actions and interactions of hypnotics on human performance: single doses of zopiclone, triazolam and alcohol. [1990.04]

Immediate and overnight effects of zopiclone 7.5 mg and nitrazepam 5 mg with ethanol, on psychomotor performance and memory in healthy volunteers. [1990.04]

A dose-range finding study of zopiclone in insomniac patients. [1990.04]

The influence of age-dependent pharmacokinetics on the pharmacodynamics of hypnotic drugs: comparison of two hypnotics with different half-lives. [1989.03]

Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomnia. [1989]

Zopiclone in insomniac shiftworkers. Evaluation of its hypnotic properties and its effects on mood and work performance. [1989]

[Comparison of the effects of zopiclone and triazolam on the sleep of normal subjects] [1988.07]

Comparative effects of zopiclone, triazolam and placebo on memory and psychomotor performance in healthy volunteers. [1987]

Zopiclone versus nitrazepam: a double-blind comparative study of efficacy and tolerance in elderly patients with chronic insomnia. [1987]

Chronic administration of zopiclone and nitrazepam in the treatment of insomnia. [1987]

Residual effects of zopiclone (Imovane). [1987]

Effect of zopiclone and diazepam on ventilatory response in normal human subjects. [1987]

Other research related to Lunesta (Eszopiclone)

Eszopiclone ingestions reported to Texas poison control centers, 2005 2006. [2007.10]

A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome. [2007.08]

Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model. [2007]

Eszopiclone for late-life insomnia. [2007]

Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia. [2006.04]

Eszopiclone for the treatment of insomnia. [2006.02]

Eszopiclone. [2006.01.01]

Eszopiclone (Lunesta): a new nonbenzodiazepine hypnotic agent. [2006.01]

Eszopiclone for insomnia. [2005.10]

Other possibly related research studies

Greater incidence of depression with hypnotic use than with placebo. [2007.08.21]

Zopiclone misuse: an update from Dublin. [2007.01]

Alopecia associated with quetiapine. [2007.03]

[Akathisia in the course of olanzapine treatment] [2006.12]

GPs' attitudes to benzodiazepine and 'Z-drug' prescribing: a barrier to implementation of evidence and guidance on hypnotics. [2006.12]

[Are z-hypnotics better and safer sleeping pills than benzodiazepines?] [2006.11.16]

A comparison of actigraphy and polysomnography in older adults treated for chronic primary insomnia. [2006.10.01]

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008